108 related articles for article (PubMed ID: 6047873)
1. The conversion of noncarcinogenic aromatic amides to carcinogenic arylhydroxamic acids by synthetic N-hydroxylation.
Gutmann HR; Galitski SB; Foley WA
Cancer Res; 1967 Aug; 27(8):1443-55. PubMed ID: 6047873
[No Abstract] [Full Text] [Related]
2. The carcinogenicity of the o-methoxy derivatives of N-2-fluorenylacetamide and of related compounds in the rat.
Gutmann HR; Galitski SB; Foley WA
Cancer Res; 1968 Feb; 28(2):234-44. PubMed ID: 5641517
[No Abstract] [Full Text] [Related]
3. On the correlation between the hepatocarcinogenicity of the carcinogen, N-2-fluorenylacetamide, and its metabolic activation by the rat.
Gutmann HR; Malejka-Giganti D; Barry EJ; Rydell RE
Cancer Res; 1972 Jul; 32(7):1554-61. PubMed ID: 4337834
[No Abstract] [Full Text] [Related]
4. Structure-activity relationships of N-acylarylhydroxylamines in the rat.
Gutmann HR; Leaf DS; Yost Y; Rydell RE; Chen CC
Cancer Res; 1970 May; 30(5):1485-98. PubMed ID: 4316729
[No Abstract] [Full Text] [Related]
5. Mammary carcinogenesis in the rat by topical application of fluorenylhydroxamic acids.
Malejka-Giganti D; Gutmann HR; Rydell RE
Cancer Res; 1973 Oct; 33(10):2489-97. PubMed ID: 4741938
[No Abstract] [Full Text] [Related]
6. The carcinogenicity of fluorenylhydroxamic acids and N-acetoxy-N-fluorenylacetamides for the rat as related to the reactivity of the esters toward nucleophiles.
Yost Y; Gutmann HR; Rydell RE
Cancer Res; 1975 Feb; 35(2):447-59. PubMed ID: 1109807
[TBL] [Abstract][Full Text] [Related]
7. Biochemical formation and pharmacological, toxicological, and pathological properties of hydroxylamines and hydroxamic acids.
Weisburger JH; Weisburger EK
Pharmacol Rev; 1973 Mar; 25(1):1-66. PubMed ID: 4571258
[No Abstract] [Full Text] [Related]
8. Nucleophilic substitution on carcinogenic N-acetoxy-N-arylacetamides.
Scribner JD; Miller JA; Miller EC
Cancer Res; 1970 Jun; 30(6):1570-9. PubMed ID: 5457931
[No Abstract] [Full Text] [Related]
9. Physiologic disposition of short chain aliphatic hydroxamates in the mouse. I. The one-through-four carbon hydroxamates: excretion and conversion to amides.
Fishbein WN; Streeter CL
J Pharmacol Exp Ther; 1970 Aug; 174(2):239-46. PubMed ID: 5451361
[No Abstract] [Full Text] [Related]
10. N-hydroxy-2-fluorenylbenzamide, an arylhydroxamic acid with high carcinogenic activity.
Gutmann HR; Galitski SB; Foley WA
Nature; 1966 Jan; 209(5019):202-3. PubMed ID: 5912432
[No Abstract] [Full Text] [Related]
11. Mechanisms of action of carcinogenic aromatic amides.
Gutmann HR; Barry EJ; Malejkagiganti D
J Natl Cancer Inst; 1969 Jul; 43(1):287-91. PubMed ID: 5796392
[No Abstract] [Full Text] [Related]
12. The conversion of the carcinogen N-hydroxy-2-fluorenylacetamide to o-amidophenols by rat liver in vitro.
Gutmann HR; Erickson RR
J Biol Chem; 1972 Feb; 247(3):660-6. PubMed ID: 5058220
[No Abstract] [Full Text] [Related]
13. Oxidation of polycyclic N-arylacetamides to glycolamides and hydroxamic acids in rabbits.
Fries W; Kiese M; Lenk W
Xenobiotica; 1973 Aug; 3(8):525-40. PubMed ID: 4128672
[No Abstract] [Full Text] [Related]
14. Aromatic amine carcinogenesis: the importance of N-hydroxylation.
Clayson DB; Dawson KM; Dean HG
Xenobiotica; 1971; 1(4):539-42. PubMed ID: 5164806
[No Abstract] [Full Text] [Related]
15. Influence of 3-methylcholanthrene and diet on the binding of 2-acetylaminofluroene and its N-hydroxy metabolite to rat liver nucleic acids.
Irving CC; Peeler TC; Veazey RA; Wiseman R
Cancer Res; 1971 Oct; 31(10):1468-72. PubMed ID: 5095133
[No Abstract] [Full Text] [Related]
16. Carcinogenicity of 2-acetylaminofluorene and N-hydroxy-2-acetylaminofluorene in the rabbit.
Irving CC; Wiseman R; Young JM
Cancer Res; 1967 May; 27(5):838-48. PubMed ID: 6067325
[No Abstract] [Full Text] [Related]
17. Studies on the carcinogenicity of the glucuronides of N-hydroxy-2-acetylaminofluorene and N-2-fluorenylhydroxylamine in the rat.
Irving CC; Wiseman R
Cancer Res; 1971 Nov; 31(11):1645-8. PubMed ID: 5121667
[No Abstract] [Full Text] [Related]
18. Suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, suppresses the growth of carcinogen-induced mammary tumors.
Cohen LA; Marks PA; Rifkind RA; Amin S; Desai D; Pittman B; Richon VM
Anticancer Res; 2002; 22(3):1497-504. PubMed ID: 12168829
[TBL] [Abstract][Full Text] [Related]
19. Influence of liver regeneration on the loss of fluorenylacetamide derivative bound to liver DNA.
Witschi H; Epstein SM; Farber E
Cancer Res; 1971 Mar; 31(3):270-3. PubMed ID: 5547215
[No Abstract] [Full Text] [Related]
20. Microsomal N- and C-oxidations of carcinogenic aromatic amines and amides.
Lotlikar PD; Hong YS
Natl Cancer Inst Monogr; 1981 Dec; (58):101-7. PubMed ID: 7341966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
